These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

828 related items for PubMed ID: 23314238

  • 1. Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Smretschnig E, Ansari-Shahrezaei S, Hagen S, Glittenberg C, Krebs I, Binder S.
    Retina; 2013 Feb; 33(2):316-23. PubMed ID: 23314238
    [Abstract] [Full Text] [Related]

  • 2. Half-fluence photodynamic therapy in acute central serous chorioretinopathy.
    Smretschnig E, Ansari-Shahrezaei S, Moussa S, Glittenberg C, Krebs I, Binder S.
    Retina; 2012 Feb; 32(10):2014-9. PubMed ID: 22466482
    [Abstract] [Full Text] [Related]

  • 3. Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy.
    Nicolò M, Zoli D, Musolino M, Traverso CE.
    Am J Ophthalmol; 2012 Mar; 153(3):474-480.e1. PubMed ID: 22019224
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy.
    Lim SH, Chang W, Sagong M.
    Eye (Lond); 2013 Mar; 27(3):353-62. PubMed ID: 23449515
    [Abstract] [Full Text] [Related]

  • 5. Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability.
    Goto S, Gomi F, Ueno C, Nishida K.
    Am J Ophthalmol; 2012 Nov; 154(5):865-871.e1. PubMed ID: 22840480
    [Abstract] [Full Text] [Related]

  • 6. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy.
    Inoue R, Sawa M, Tsujikawa M, Gomi F.
    Am J Ophthalmol; 2010 Mar; 149(3):441-6.e1-2. PubMed ID: 20172070
    [Abstract] [Full Text] [Related]

  • 7. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK, Chang CK, Peng CH.
    Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.
    Smretschnig E, Hagen S, Glittenberg C, Ristl R, Krebs I, Binder S, Ansari-Shahrezaei S.
    Eye (Lond); 2016 Jun; 30(6):805-11. PubMed ID: 26965012
    [Abstract] [Full Text] [Related]

  • 9. A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy.
    Bae SH, Heo JW, Kim C, Kim TW, Lee JY, Song SJ, Park TK, Moon SW, Chung H.
    Am J Ophthalmol; 2011 Nov; 152(5):784-92.e2. PubMed ID: 21742303
    [Abstract] [Full Text] [Related]

  • 10. One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.
    Fujita K, Imamura Y, Shinoda K, Matsumoto CS, Mizutani Y, Hashizume K, Mizota A, Yuzawa M.
    Ophthalmology; 2015 Mar; 122(3):555-61. PubMed ID: 25444637
    [Abstract] [Full Text] [Related]

  • 11. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
    Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF.
    Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
    [Abstract] [Full Text] [Related]

  • 12. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial.
    Bae SH, Heo J, Kim C, Kim TW, Shin JY, Lee JY, Song SJ, Park TK, Moon SW, Chung H.
    Ophthalmology; 2014 Feb; 121(2):558-65. PubMed ID: 24268858
    [Abstract] [Full Text] [Related]

  • 13. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.
    Silva RM, Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Gregório T, Cachulo ML, Pires IA, Cunha-Vaz JG, Murta JN.
    Retina; 2013 Feb; 33(2):309-15. PubMed ID: 23095766
    [Abstract] [Full Text] [Related]

  • 14. Multimodal Imaging and Choroidal Volumetric Changes After Half-fluence PDT in Central Serous Chorioretinopathy.
    Munk MR, Shah R, Pappas F, Baddar D, Wong B, Jampol LM, Fawzi AA.
    Curr Eye Res; 2016 Feb; 41(1):97-106. PubMed ID: 25612245
    [Abstract] [Full Text] [Related]

  • 15. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial.
    Reibaldi M, Cardascia N, Longo A, Furino C, Avitabile T, Faro S, Sanfilippo M, Russo A, Uva MG, Munno F, Cannemi V, Zagari M, Boscia F.
    Am J Ophthalmol; 2010 Feb; 149(2):307-315.e2. PubMed ID: 19896635
    [Abstract] [Full Text] [Related]

  • 16. Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy.
    Nicoló M, Eandi CM, Alovisi C, Grignolo FM, Traverso CE, Musetti D, Cardillo Piccolino F.
    Am J Ophthalmol; 2014 May; 157(5):1033-7. PubMed ID: 24487046
    [Abstract] [Full Text] [Related]

  • 17. Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy.
    Hayashida M, Miki A, Honda S, Nakamura M.
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101955. PubMed ID: 32818640
    [Abstract] [Full Text] [Related]

  • 18. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB, Mohr JK, Ossewaarde-van Norel A, den Hollander AI, Keunen JE, Hoyng CB, Boon CJ.
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [Abstract] [Full Text] [Related]

  • 19. INSTRUMENTAL DIFFERENCE IN ASSESSING CHOROIDAL HYPERPERMEABILITY AND PHOTODYNAMIC THERAPY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Lee SM, Kwon HJ, Park SW, Lee JE, Byon IS.
    Retina; 2019 Jul; 39(7):1361-1369. PubMed ID: 29554076
    [Abstract] [Full Text] [Related]

  • 20. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
    Maruko I, Iida T, Sugano Y, Furuta M, Sekiryu T.
    Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.